atherosclerotic obliterans
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (a) Symptomatic femoropopliteal artery disease (Rutherford 3-6) involving the distal superficial femoral artery (exit of the adductor canal) in patients older than 18 years; (b) Lesion length greater than 50mm but less than 250mm, diameter stenosis >50% or complete occlusion; (c) The guidewire can be successfully passed through the lesion and into the true lumen of the distal artery; (d) Infrapopliteal artery outflow tract > 1; (e) Use "aggressive vascular preparation strategy", that is, adequate proportional balloon dilatation, or volume reduction means; (f) Implantation of Supera stent in femoropopliteal artery lesion.
Exclusion criteria
Exclusion criteria: (a) patients with a life expectancy of less than one year; (b) the primary lesion becomes restenosis or reocclusion; (c) Patients with severe renal insufficiency such as uremia or iodine contrast medium allergy; (d) Patients intolerant to dual antiplatelet drug therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of stents reaching the nominal release standard immediately after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| One-year clinically driven target lesion reintervention rate;one-year primary patency rate of the stent; | — |
Countries
China